David Lally, MD: Efficacy of Oral APX3330 for Diabetic Retinopathy

Aug 6, 2023

VIDEO: Ocuphire official previews company’s next steps

Jul 30, 2023

ON THE HORIZON: DIABETIC RETINOPATHY TREATMENTS — WITHOUT INJECTIONS

Jul 1, 2023

Phase 2 ZETA-1 Trial Suggests Promise of APX3330 in Diabetic Retinopathy

Jun 27, 2023

Shrinking Night Vision Disturbances

Jun 1, 2023

Phentolamine (Nyxol) Clinical Trials Next in the Pipeline for Presbyopia

Apr 27, 2023

Potential Wide Use for Ocuphire’s APX-3330: An Oral Drug to Prevent Diabetic Retinopathy Progression—Results of the Phase 2 ZETA-1 Trial

Mar 23, 2023

MicroCap Rodeo Winter Wonderland Best Ideas 2023 Conference

Feb 22, 2023

Oral diabetic retinopathy treatment fails to meet primary endpoint in phase 2 trial

Jan 27, 2023

Top five refractive surgery items from 2022

Dec 27, 2022

• « Previous
• 1
• 2
• 3
• 4
• 5
• 6
• Next »